RL

Ram Lal Bind

Active Director Director DIN 08944819
DIN 08944819 First appointment Nov 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Ram Lal Bind

Data last updated:

Ram Lal Bind is a Director at Satik Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Satik Pharmaceuticals Private Limited reported revenue of ₹33,620 (FY 2022).

DIN 08944819
Primary Designation Director
Industry Chemicals
First Appointment 02 Nov 2020
Oldest Company Age 6 yrs
Largest company Satik Pharmaceuticals Private Limited · ₹33,620 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Nov 20202020₹33,620 (FY 2022)Active

Board colleagues of Ram Lal Bind

NameDINCompanyDesignation
Ram Pal08944818Satik Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Satik Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ram Lal Bind

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ram Lal Bind

Ram Lal Bind currently holds 1 directorship: Satik Pharmaceuticals Private Limited (Director, since 02 Nov 2020, revenue ₹33,620 (FY 2022)).

Ram Lal Bind was first appointed on 02 Nov 2020 as Director at Satik Pharmaceuticals Private Limited.

The current boards of Ram Lal Bind's companies include Ram Pal (Satik Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available